0000899243-21-036420.txt : 20210917
0000899243-21-036420.hdr.sgml : 20210917
20210917163933
ACCESSION NUMBER: 0000899243-21-036420
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210917
FILED AS OF DATE: 20210917
DATE AS OF CHANGE: 20210917
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Kjellson Nina S
CENTRAL INDEX KEY: 0001381980
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-40800
FILM NUMBER: 211260933
MAIL ADDRESS:
STREET 1: C/O INTERWEST PARTNERS
STREET 2: 2710 SAND HILL ROAD, SUITE 200
CITY: MENLO PARK
STATE: CA
ZIP: 94025
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Tyra Biosciences, Inc.
CENTRAL INDEX KEY: 0001863127
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 831476348
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 2656 STATE STREET
CITY: CARLSBAD
STATE: CA
ZIP: 92008
BUSINESS PHONE: (619) 728-4760
MAIL ADDRESS:
STREET 1: 2656 STATE STREET
CITY: CARLSBAD
STATE: CA
ZIP: 92008
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-09-17
0
0001863127
Tyra Biosciences, Inc.
TYRA
0001381980
Kjellson Nina S
C/O TYRA BIOSCIENCES, INC.
2656 STATE STREET
CARLSBAD
CA
92008
1
0
0
0
Common Stock
2021-09-17
4
C
0
3936595
A
3963595
I
By Canaan XI L.P.
Common Stock
2021-09-17
4
C
0
473396
A
473396
I
By 2020+ Co-Investment L.P. - Series 7
Series A Preferred Stock
2021-09-17
4
C
0
1333334
0.00
D
Common Stock
3463201
0
I
By Canaan XI L.P.
Series B Preferred Stock
2021-09-17
4
C
0
182257
0.00
D
Common Stock
473394
0
I
By Canaan XI L.P.
Series B Preferred Stock
2021-09-17
4
C
0
182258
0.00
D
Common Stock
473396
0
I
By 2020+ Co-Investment L.P. - Series 7
On September 17, 2021, each share of Series A Preferred Stock and each share of Series B Preferred Stock converted into Common Stock of the Issuer at a ratio of 1-for-2.5974 without payment of further consideration upon closing of the initial public offering of the Issuer's common stock. The shares had no expiration date.
The sole general partner of Canaan XI L.P. ("Canaan XI") is Canaan Partners XI LLC ("Canaan XI GP"), which may be deemed to have sole voting, investment and dispositive power with respect to the shares held by Canaan XI. Canaan XI GP disclaims Section 16 beneficial ownership of the securities held by Canaan XI, except to the extent of its pecuniary interest therein, if any.
The sole general partner of Canaan 2020+ Co-Investment L.P. - Series 7 (the "Canaan Series 7") is Canaan Partners 2020+ Co-Investment LLC ("Canaan 2020+ GP"), which may be deemed to have sole voting, investment and dispositive power with respect to the shares held by Canaan Series 7. Canaan 2020+ GP disclaims Section 16 beneficial ownership of the securities held by Canaan Series 7, except to the extent of its pecuniary interest therein, if any.
/s/ John Healy, Attorney-in Fact
2021-09-17